RB
RBCL.US RBC Life Sciences Inc
- Market cap
- USD 1.55K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2022.
Is RBCL.US undervalued?
Graham numberThe Graham number of RBC Life Sciences Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RBC Life Sciences Inc fundamental analysis
No fundamental analysis for RBC Life Sciences Inc yet.
RBC Life Sciences Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RBC Life Sciences Inc
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products. RBC Life Sciences, Inc. is headquartered in Irving, Texas.
Full company profileRBC Life Sciences Inc financial statements
RBC Life Sciences Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 28.4M | 25.2M | 25.5M | 28.3M | 24.4M | 25.8M | - | - | - | - |
| Gross Profit | 14.3M | 12.6M | 12.0M | 15.6M | 13.5M | 13.6M | - | - | - | - |
| Operating Income | -70.9K | -464K | -625K | -625K | -2.51M | -666K | - | - | - | - |
| EBITDA | 436K | 121K | -36.3K | -45.4K | -302K | -252K | - | - | - | - |
| Net Income | -71.5K | -361K | -500K | -603K | -742K | -756K | - | - | - | - |
| EPS | -0.03 | -0.16 | -0.23 | -0.27 | -0.34 | -0.34 | - | - | - | - |
| Balance Sheet | ||||||||||
| Total Assets | 18.8M | 18.0M | 17.5M | 16.0M | 11.3M | 11.0M | - | - | - | - |
| Total Liabilities | 8.96M | 8.50M | 8.52M | 7.57M | 3.42M | 3.83M | - | - | - | - |
| Shareholders' Equity | 9.86M | 9.52M | 9.01M | 8.43M | 7.88M | 7.13M | - | - | - | - |
| Cash & Short-term Investments | 3.86M | 3.90M | 3.75M | 1.92M | 1.45M | 1.47M | - | - | - | - |
| Total Debt | 1.73M | 1.55M | 1.35M | 1.14M | - | - | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 125K | 445K | 294K | -608K | -4.25M | 156K | - | - | - | - |
| Capital Expenditure | 350K | 805K | 267K | 1.07M | 180K | 149K | - | - | - | - |
| Free Cash Flow | -225K | -360K | 27.2K | -1.68M | -4.43M | 6.70K | - | - | - | - |
| Ratios | ||||||||||
| ROE | -0.7% | -3.8% | -5.5% | -7.2% | -9.4% | -10.6% | - | - | - | - |
| ROA | -0.4% | -2.0% | -2.9% | -3.8% | -6.6% | -6.9% | - | - | - | - |
| Net Profit Margin | -0.3% | -1.4% | -2.0% | -2.1% | -3.0% | -2.9% | - | - | - | - |
| Debt to Equity | 0.18x | 0.16x | 0.15x | 0.13x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
RBC Life Sciences Inc dividends
RBC Life Sciences Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 50:500 on Aug 12, 2013.
Who owns RBC Life Sciences Inc
- Insiders 8.31%
- Institutions 0.00%
- Public & others 91.69%
- Shares outstanding 2.21M
RBC Life Sciences Inc company profile
- Company name
- RBC Life Sciences Inc
- Ticker
- RBCL.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 89
- Fiscal year end
- December
- Address
- 2301 Crown Court, Irving, TX, United States, 75038
- Phone
- 972 893 4000
- Website
- rbclifesciences.com
About RBC Life Sciences Inc
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products. RBC Life Sciences, Inc. is headquartered in Irving, Texas.
RBC Life Sciences Inc management
3- Mr. Clinton H. HowardFounder & Chairman · born 1928
- Mr. David PriceActing Chief Executive Officer
- Mr. Kenneth L. SabotSenior Vice President of Operations · born 1945